Anthera Pharmaceuticals (ANTH) Completes 33 Million Share Offering; Exercise in Full of Over-Allotment Option
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) has completed the previously announced underwritten public offering of 33,000,000 shares of its common stock, offered at a price to the public of $1.00 per share. In addition, the Company has sold 4,950,000 shares of its common stock at a price to the public of $1.00 per share pursuant to the underwriters' option to purchase additional shares, resulting in a total public offering of 37,950,000 shares. The gross proceeds to the Company from the sale of shares in this offering, before deducting customary underwriting discounts and commissions, were $37,950,000. Anthera intends to use the net proceeds from this offering for general corporate purposes.
You May Also Be Interested In
- Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update
- Zions Bancorporation (ZION) Prices $525M Common Offering at $29.80/Share
- Top Ships (TOPS) Pulls F-1 Registration Statement
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!